Most prostate cancers that are discovered after a PSA test are early-stage cancers. But not all early-stage cancers are the same. To understand how much treatment may help, it’s important for men to understand whether their cancer is high or low risk. Then they can balance the benefit of treatment against the possible side effects. To help men make a good treatment decision, the Foundation has developed a Shared Decision-Making® program called Treatment Choices for Localized Prostate Cancer.
This program is for men with early-stage prostate cancer (cancer that appears to be confined only to the prostate gland) who are making a decision about treatment. This program compares the treatment options for prostate cancer, including surgical removal of the prostate, radiation therapy, hormone therapy, active surveillance and watchful waiting. The Foundation has developed a separate program for men making decisions about hormone therapy when the PSA rises after surgery or radiation.
The program includes interviews with real patients who chose different approaches to treat their prostate cancer. They describe how they made these decisions and how their choices have impacted their lives. The program also features a urologist.
This program was developed with our production partner, Health Dialog. It is available as a booklet and a web-based program (Health Crossroads®) for Health Dialog members.